
1. clin microbiol infect. 2015 jan;21(1):103.e7-103.e10. doi:
10.1016/j.cmi.2014.08.004. epub 2014 oct 13.

hiv dna loads, plasma residual viraemia risk virological rebound in
heavily treated, virologically suppressed hiv-infected patients.

gianotti n(1), canducci f(2), galli l(3), cossarini f(3), salpietro s(3), poli
a(3), nozza s(3), spagnuolo v(3), clementi m(4), sampaolo m(4), ceresola er(4),
racca s(5), lazzarin a(6), castagna a(3).

author information: 
(1)infectious diseases, san raffaele scientific institute, milan, italy.
electronic address: nicola.gianotti@hsr.it.
(2)microbiology virology, san raffaele scientific institute, milan, italy;
dipartimento di biotecnologie e scienze della vita, university insubria,
varese, italy.
(3)infectious diseases, san raffaele scientific institute, milan, italy.
(4)microbiology virology, san raffaele scientific institute, milan, italy;
università vita-salute san raffaele, milan, italy.
(5)microbiology virology, san raffaele scientific institute, milan, italy.
(6)infectious diseases, san raffaele scientific institute, milan, italy;
università vita-salute san raffaele, milan, italy.

in single-centre, retrospective study, analyzed data 194 patients
receiving antiretroviral therapy <50 human immunodeficiency virus (hiv) rna 
copies/ml plasma 318 hiv rna/dna paired samples. kinetic polymerase
chain reaction (kpcr) molecular system analysis, 104 (54%) subjects had
undetectable hiv rna 90 (46%) residual viraemia. median (interquartile
range) hiv dna load 780 (380-1930) copies/10(6) peripheral blood lymphocytes 
(pbl), hiv dna loads independently associated residual viraemia
(p 0.002). virological rebound occurred 29/194 (15%) patients median
(interquartile range) follow-up 17.5 (13.5-31.5) months. residual viraemia (p 
0.002), hiv dna load, independently associated virological
rebound.

copyright © 2014 european society clinical microbiology infectious
diseases. published elsevier ltd. rights reserved.

doi: 10.1016/j.cmi.2014.08.004 
pmid: 25636935  [indexed medline]

